Insights

The Importance of Prioritizing Foreign Filing Requirements

In this episode of the Examining Patents podcast series, Stephanie Schonewald and Dan Klein discuss the punitive consequences to patent owners of not complying with foreign filing requirements when filing a patent application covering a US-made invention in a country other than the United States.

Issues Around Article 4 of the Paris Convention

In this episode of the Examining Patents Podcast Series, Stephanie Schonewald and Michael Shinall discuss issues impacting compliance with Article 4 of the Paris Convention, a critical provision for establishing and maintaining the priority date of your patent application.

An Update on Obviousness-Type Double Patenting (ODP)

In this episode of Choate’s Examining Patents podcast series, Kristen Buteau and Stephanie Schonewald discuss obviousness-type double patenting (ODP) rejections issued by the USPTO based on the claims of later-filed, later-expiring unrelated patents and review a recent ex parte appeal case that addresses such rejections.

Stephanie Schonewald Speaking on Obviousness at IPWatchdog 2024 Life Sciences Masters

Stephanie Schonewald will be speaking on the panel, "Obviousness and Life Sciences: Trends and Strategies for Success" at the IPWatchdog Life Sciences Masters on Wednesday, October 30 at 9:30 a.m.

LMG Life Sciences Ranks Choate Tier 1 and Names Six 2024 Life Sciences Stars

Six Choate attorneys and two practice areas have been ranked in this year’s LMG Life Sciences U.S. Firm and Attorney Rankings. The firm received a Tier 1 ranking in the areas of Patent Prosecution and Patent Strategy & Management, while Brenda Jarrell, Charles Lyon, Eric Marandett, Rolando Medina, Stephanie Schonewald, and Tobin Sullivan have been named Life Sciences Stars.

Stephanie Schonewald to Discuss Invention Harvesting at IPWatchdog Women's IP Forum

Dr. Stephanie Schonewald will be a panelist discussing "Capturing Innovation: Best Practices for Invention Harvesting" at the IPWatchdog Women's IP Forum on Monday, August 26, 2024 at 3:30 p.m. EST.

Universal DX (UDX) Closes Series B Funding for Clinical Trials on Colorectal Cancer Screening Blood Test, Signal-C®

Choate represented Universal DX (UDX) in IP diligence for its Series B funding round, which will advance the clinical trial of Signal-C, UDX’s colorectal cancer screening blood test, which is on track to enroll 15,000 patients across 100 sites.

Choate Attorneys Recognized in Best Lawyers in America® 2025

The Best Lawyers in America® has recognized 44 Choate attorneys in its 2025 edition. Recognition in Best Lawyers® is based entirely on peer review and is widely regarded by both clients and legal professionals as a significant honor.

Choate Ranks Highly in 2024 Legal 500

The 2024 edition of The Legal 500 recognized 40 Choate attorneys in their respective fields and 10 practice areas.